Stay updated with breaking news from Candidate Shown. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Investegate announcements from CureVac, CureVac and GSK's Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study
Issuer: CureVac / Key word(s): Study21.04.2022 / 13:00 The issuer is solely responsible for the content of this announcement.CureVac and GSK's Bivalent Second-Generation mRNA Vaccine Candidate Shown to be Highly Effective Against SARS-CoV-2 Variants in Preclinical Study- Vaccine candidate combining Beta- and Delta-...
Latest news on the Delta variant, also known as lineage B.1.617.2, which is a variant of SARS-CoV-2, the virus that causes Covid-19.